Skip to content

Validation of vaccination coverage and identification of barriers and facilitators of vaccination take-up in Côte d'Ivoire

Validation of vaccination coverage and identification of barriers and facilitators of vaccination take-up in Côte d'Ivoire

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038510
Enrollment
2000
Registered
2026-01-21
Start date
2025-12-08
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination B54 B97.7 Z28

Interventions

Group 1: This mixed-methods-study does not include an intervention and is based on observational groups. The study is conducted in six selected regions of Côte d'Ivoire: La Mé, Nawa, Haut-Sassandra, M

Sponsors

Charité Centre for Global Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All study participants are recruited from the following regions: La Mé, Nawa, Haut-Sassandra, Marahoué, Lôh-Djiboua, Indénié-Djuablin Work Package 1: Eligible participants are caregivers (=18 years) residing in one of the selected regions in Côte d'Ivoire with a child aged 12–23 months or a girl aged 9 to 14 years in the household. For the qualitative component, healthcare workers, community leaders, and management staff at the district and regional level are also eligible. Work Package 2: For the qualitative component, eligible participants include representatives of private health facilities, management staff of the public health sector at district and regional levels, healthcare personnel, and caregivers of children.

Exclusion criteria

Exclusion criteria: Work Package 1: Caregivers younger than 18 years, those who do not provide informed consent, or those without a child aged 12–23 months and without a girl aged 9 to 14 years in the household will be excluded. Individuals unable to participate due to health or language barriers will also be excluded. Work Package 2: - over-the-counter pharmaceutical sellers

Design outcomes

Primary

MeasureTime frame
Work package 1: - estimated prevalence of zero-dose and under-immunized children (12-23 months) - estimated prevalence of children (12-23 months) who did not receive the malaria vaccine - estimated prevalence of girls (9-14 years) who did not receive the HPV vaccine Data will be collected with quantitative questionnaires. Work package 2: - identification of key challenges, enablers, and stakeholder attitudes toward public-private partnership in vaccination efforts Data will be collected with qualitative interviews.

Secondary

MeasureTime frame
Work package 1: - geographic or demographic differences in vaccination rates, - association between vaccination uptake and logistical, social, and cultural factors Work package 2: - analysis of the influence of facility type, provider type, and geographic/socioeconomic factors on public-private partnerships

Countries

Côte d’Ivoire

Contacts

Public ContactLisa Bogler

Charité Centre for Global Health

lisa.bogler@charite.de+493045050

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026